Delivery Order SPE2DB20D7066-SPE2DB25FC4HC
- Not listed
- The Defense Logistics Agency awarded a $1,071.66 delivery order to AmerisourceBergen Drug Corp for Junel FE 1 mg-20 mcg tablets (28-count) on July 18, 2025, with completion scheduled for July 21, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader contract vehicle with DLA....
- The Defense Logistics Agency awarded a delivery order valued at $3,427.92 to AmerisourceBergen Drug Corp for Junel FE 1 mg-20 mcg tablets (28-count package) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement. The product will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a $1,966.20 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Junel FE 1 mg-20 mcg tablets in 28-count packaging. This firm fixed price delivery order, with an ultimate completion date of July 22, 2025, represents a non-set-aside competitive award executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $1,402.75 to AmerisourceBergen Drug Corp for Junel Fe 1 mg-20 mcg tablets (28-count packaging) on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a single transaction within AmerisourceBergen Drug Corp's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Junel FE 1.5 mg-30 mcg tablets in quantities of 28 units. This $1,560.38 firm fixed-price delivery order represents a non-set-aside, competitively awarded contract with an ultimate completion date of July 24, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $2,142.97 to AmerisourceBergen Drug Corp for the supply of Junel FE 1 mg-20 mcg tablets in quantities of 28 units. This firm fixed-price delivery order, issued on July 18, 2025, is scheduled for completion by July 21, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a non-competitive delivery against an existing contract vehicle and reflects routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Junel FE 1 mg-20 mcg tablets (28-count package) with a ceiling value of $1,278.01. This firm fixed-price delivery order, with an ultimate completion date of August 5, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. The award was made through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Junel FE 1 mg-20 mcg tablets (28-count packaging) under a firm fixed-price contract valued at $1,576.29. The award, issued on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a non-competitive delivery order placed against AmerisourceBergen's existing indefinite delivery vehicle. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania. This...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,899.04 firm fixed-price contract is for the supply of the prescription drug Junel FE 1.5 mg-30 mcg tablet, which is used for contraception. The order has an ultimate completion date of January 24, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Junel FE 1 mg-20 mcg tablets in packages of 28. The $1,328.80 contract has a completion date of February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is issued under an indefinite delivery contract (IDC) valued at up to $999,999,999.00...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC4HCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,587.38 to AmerisourceBergen Drug Corp for the supply of Junel FE 1 mg-20 mcg tablets (28-count packages) on August 11, 2025. This firm fixed-price, non-set-aside contract is scheduled for completion by August 12, 2025, with performance at the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader relationship with the federal government for pharmaceutical procurement supporting military and federal healthcare systems. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion prime contract vehicle designated SPE2DX and valid through December 2026. As a major pharmaceutical distributor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare programs globally. The contract was awarded competitively, reflecting the vendor's established capability to meet federal procurement requirements for pharmaceutical products across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 8/11/25 |